EPH Warned On Opioid Treatment Claim For Enzyme, Amino, Peptide Blend
EPH Technologies apparently heeds FDA's warning, which also noted violative drug and disease claims for nasal sprays. EPH continued selling other supplements on 2 December, but the three that FDAcited in 18 November warning were not available.